Chart-Typ:
Zeitraum:
| XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen |
| T1 Energy Inc.: T1 Energy to Enter BESS and Data Center Infrastructure Markets with Acquisition of KORE Power | AUSTIN, Texas and NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ("T1," "T1 Energy," or the "Company") announced this morning it has entered into a definitive agreement to acquire... ► Artikel lesen |
| T1 Energy Inc.: T1 Energy Reports First Quarter 2026 Results | AUSTIN, Texas and NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ("T1," "T1 Energy," or the "Company") today reported financial and operating results for the first quarter 2026.... ► Artikel lesen |
| Niu Technologies Announces Unaudited First Quarter 2026 Financial Results | -- First Quarter Revenues of RMB 909.5 million, up 33.4% year over year -- First Quarter Net Loss of RMB 93.9 million, compared with RMB 38.8 million in the same period of 2025 BEIJING, May 18, 2026... ► Artikel lesen |
| Niu Technologies Provides First Quarter 2026 Sales Volume Update | BEIJING, April 06, 2026 (GLOBE NEWSWIRE) -- Niu Technologies ("NIU" or "the Company") (NASDAQ: NIU), the world's leading provider of smart urban mobility solutions, today provided its sales volume... ► Artikel lesen |
| Niu Technologies Announces Unaudited Fourth Quarter and Full Year 2025 Financial Results | -- Fourth Quarter Revenues of RMB 676.2 million, down 17.4% year over year -- Fourth Quarter Net Loss of RMB 88.1 million, compared with RMB 72.5 million in the same period of 2024 -- Full Year Revenues... ► Artikel lesen |
| Sangamo Therapeutics, Inc.: Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results | Rolling submission of Biologics License Agreement (BLA) to U.S. Food and Drug Administration (FDA) seeking ST-920 approval is in progress. Six sites activated in Phase 1/2 STAND study evaluating ST-503... ► Artikel lesen |
| XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 12.05.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.05.2026ISIN NameAU0000182628 WINSOME... ► Artikel lesen |
| XFRA GBY: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSANGAMO THERAP.INC.DL-... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GIFTIFY INC finden Sie auf Wallstreet Online.